33 related articles for article (PubMed ID: 31414564)
1. Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients.
Wichmann G; Willner M; Kuhnt T; Kluge R; Gradistanac T; Wald T; Fest S; Lordick F; Dietz A; Wiegand S; Zebralla V
Front Oncol; 2021; 11():682088. PubMed ID: 34026656
[TBL] [Abstract][Full Text] [Related]
2. Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
Elst L; Philips G; Vandermaesen K; Bassez A; Lodi F; Vreeburg MTA; Brouwer OR; Schepers R; Van Brussel T; Mohanty SK; Parwani AV; Spans L; Vanden Bempt I; Jacomen G; Baldewijns M; Lambrechts D; Albersen M
Eur Urol; 2024 Apr; ():. PubMed ID: 38670879
[TBL] [Abstract][Full Text] [Related]
3. Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
Scheel A; Bellile E; McHugh JB; Walline HM; Prince ME; Urba S; Wolf GT; Eisbruch A; Worden F; Carey TE; Bradford C
Laryngoscope; 2016 Sep; 126(9):E292-9. PubMed ID: 27345657
[TBL] [Abstract][Full Text] [Related]
4. TP53 Mutations Emerge as a Critical Biomarker in Penile Cancer, Superseding Human Papillomavirus Status.
Chahoud J; Yu X; Necchi A; Spiess PE
Eur Urol; 2024 May; ():. PubMed ID: 38749849
[No Abstract] [Full Text] [Related]
5. Unraveling most abundant mutational signatures in head and neck cancer.
Plath M; Gass J; Hlevnjak M; Li Q; Feng B; Hostench XP; Bieg M; Schroeder L; Holzinger D; Zapatka M; Freier K; Weichert W; Hess J; Zaoui K
Int J Cancer; 2021 Jan; 148(1):115-127. PubMed ID: 32930393
[TBL] [Abstract][Full Text] [Related]
6. Salvage surgery in head and neck cancer: External validation of predictors of disease-specific survival.
Quer M; León X; Casasayas M; Sansa A; López M; García Lorenzo J
Oral Oncol; 2020 Jun; 109():104876. PubMed ID: 32615457
[TBL] [Abstract][Full Text] [Related]
7. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
León X; Neumann E; Gutiérrez A; García J; López M; Quer M
Head Neck; 2020 Oct; 42(10):2912-2919. PubMed ID: 32588930
[TBL] [Abstract][Full Text] [Related]
8. Organ preservation after treatment with induction chemotherapy in patients with locally advanced carcinomas (T3-T4) of oral cavity and oropharynx.
León X; García J; López M; Farré N; Majercakova K; Gallego Ó; López-Pousa A; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(1):27-36. PubMed ID: 32513455
[TBL] [Abstract][Full Text] [Related]
9. Oncological results of salvage treatment in patients with hypopharyngeal carcinoma.
León X; García J; López M; Bulboa C; Pujals G; Quer M
Acta Otorrinolaringol Esp (Engl Ed); 2021; 72(2):85-91. PubMed ID: 32473712
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
11. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma.
Valero C; Pardo L; Sansa A; Garcia Lorenzo J; López M; Quer M; León X
Head Neck; 2020 Feb; 42(2):336-343. PubMed ID: 31750591
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
Huang Q; Li F; Ji M; Lin L; Hu C
BMC Cancer; 2023 Apr; 23(1):324. PubMed ID: 37024846
[TBL] [Abstract][Full Text] [Related]
13. LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
Casarotto M; Lupato V; Giurato G; Guerrieri R; Sulfaro S; Salvati A; D'Angelo E; Furlan C; Menegaldo A; Baboci L; Montico B; Turturici I; Dolcetti R; Romeo S; Baggio V; Corrado S; Businello G; Guido M; Weisz A; Giacomarra V; Franchin G; Steffan A; Sigalotti L; Vaccher E; Boscolo-Rizzo P; Jerry P; Fanetti G; Fratta E
Clin Epigenetics; 2022 Dec; 14(1):171. PubMed ID: 36503584
[TBL] [Abstract][Full Text] [Related]
14. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
Schroeder L; Wichmann G; Willner M; Michel A; Wiesenfarth M; Flechtenmacher C; Gradistanac T; Pawlita M; Dietz A; Waterboer T; Holzinger D
Int J Cancer; 2018 Apr; 142(7):1361-1368. PubMed ID: 29159804
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
Schroeder L; Boscolo-Rizzo P; Dal Cin E; Romeo S; Baboci L; Dyckhoff G; Hess J; Lucena-Porcel C; Byl A; Becker N; Alemany L; Castellsagué X; Quer M; León X; Wiesenfarth M; Pawlita M; Holzinger D
Eur J Cancer; 2017 Mar; 74():73-81. PubMed ID: 28335889
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
Scholes AG; Liloglou T; Snijders PJ; Hart CA; Jones AS; Woolgar JA; Vaughan ED; Walboomers JM; Field JK
Int J Cancer; 1997 May; 71(5):796-9. PubMed ID: 9180148
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutations in head and neck cancer.
Nathan CA; Khandelwal AR; Wolf GT; Rodrigo JP; Mäkitie AA; Saba NF; Forastiere AA; Bradford CR; Ferlito A
Mol Carcinog; 2022 Apr; 61(4):385-391. PubMed ID: 35218075
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
Devaraja K; Aggarwal S; Verma SS; Gupta SC
Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
